The COVID-19 pandemic exacerbated already rising rates of burnout among American health care workers. A new Northwestern University study found learning and practicing skills that increase positive emotion like gratitude, ...
Jun 25, 2024
0
36
Research from Saint Louis University School of Medicine finds improvements in survival in both veterans and men across the country over the last 20 years in metastatic prostate cancer, which correlate with new hormonal treatments.
Jun 20, 2024
0
20
Metastatic cancer cells, which cause 90% of cancer-related deaths, must overcome numerous hurdles to spread from a primary tumor through the bloodstream and re-establish themselves in different tissues.
Jun 11, 2024
0
38
More than 16,000 Australians will be diagnosed with melanoma each year. Most of these will be caught early, and can be cured by surgery.
Jun 5, 2024
0
0
As prostate cancer progresses, it becomes increasingly aggressive and can metastasize. In this form, the tumor is difficult to treat, which is reflected in high mortality rates: Worldwide, the malignant disease of the prostate ...
Jun 5, 2024
0
10
Prof. Liu Zhibo's team from Peking University (PKU)'s College of Chemistry and Molecular Engineering, along with collaborators, recently published a paper titled "Covalent targeted radioligands potentiate radionuclide therapy" ...
Jun 4, 2024
0
0
Immunotherapy before surgery for patients with metastatic melanoma appears to be especially successful. Some 59% of patients respond so well to this therapy that adjuvant treatment is no longer needed, according to the results ...
Jun 3, 2024
0
1
For a large percentage of men with prostate cancer, the tumor may be so slow-growing that doctors advise a "watch-and-wait" approach instead of active treatment.
May 30, 2024
0
8
A study led by UCLA Health Jonsson Comprehensive Cancer Center researchers found that using a combination of experimental immunotherapy drugs with chemotherapy significantly improves progression-free survival and overall ...
May 24, 2024
0
2
A new study led by a UCLA-VA collaborative team looking at the landscape of genomic alterations in more than 5,000 veterans with metastatic prostate cancer uncovered differences in the genomic makeup of cancer cells that ...
May 24, 2024
0
0
